Written by the AllMyPeptides Research Team
BPC-157 vs KPV: At a Glance
BPC-157 is a 15-amino-acid peptide studied in tissue-repair and angiogenesis research. KPV is a three-amino-acid fragment of alpha-MSH studied primarily for anti-inflammatory properties. They are frequently mentioned together but are quite distinct molecules.
Research use only. Both compounds are supplied for in-vitro laboratory research. Neither is a medicine, and neither is for human or veterinary consumption, administration, or therapeutic use.
How They Differ — Origin & Mechanism
BPC-157 is derived from a gastric protein and in research is associated with angiogenesis, tissue repair and gut-related models. KPV is the C-terminal tripeptide of alpha-MSH and in research is associated with down-modulation of inflammatory signalling. One is studied more for repair and vascular processes, the other more for inflammation.
What Each Is Studied For
In laboratory research BPC-157 features in models of tendon, muscle and gastrointestinal repair, while KPV features in models of inflammation, including gut inflammation and wound-healing contexts. They are sometimes investigated together in repair-and-inflammation research, which is also why they appear in some research blends.
Regulatory Status & Sourcing
Neither is an approved medicine in the UK; both are supplied for laboratory research only. Verify purity against a batch-matched COA. View BPC-157 and KPV product details. See also BPC-157 vs TB-500.
Frequently Asked Questions
What is the difference between BPC-157 and KPV?+
Are BPC-157 or KPV approved in the UK?+
Why are BPC-157 and KPV sometimes combined?+
Related Guides
Products discussed in this guide are for research and laboratory use only. AllMyPeptides does not condone or support misuse of any research materials. Not for human or animal consumption.